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Introduction: Mesenchymal stem cells (MSCs) derived from adipose tissue, bone marrow, 
cord blood, and other tissues, have recently attracted much attention as potential therapeutic agents 
in various diseases due to their differentiation quality. The adipose tissue is more accessible and 
safe for the donor to isolate mesenchymal stem cells (MSC). In vitro, adipose mesenchymal stem 
cells (AMSC) can be differentiated into cells such as adipocytes, chondrocytes, and osteocytes. All 
of this ability, with their strong immunosuppressive effects, makes AMSCs attractive candidates for 
cell therapy. The objective of this study was to assess the capacity of AMSC to contribute tumor 
pathogenesis by supporting tumor microenvironments and increasing tumor growth in experimental 
mice models in vivo. 
Methods: The culture of MSC was derived from the adipose tissue provided by the Research 
Institute of Traumatology and Orthopedics (Astana, Kazakhstan). Cell cultivation took place at 
37°C with a content of 5% CO2 in a complete AlphaMEM medium. Nude mice (Swiss Nu/Nu 
strain), provided by the Department of Experimental Radiation Oncology Breeding Core, The 
University of Texas MD Anderson Cancer Center. An experiment group of four weeks Nude mice 
were injected by 3 mln AMSC the control group was injected with 3 mln tumorigenic myeloma 
cells of the MDA-MB-231 in 200 ul phosphate saline buffer subcutaneously. 
Results: Surveillance was carried out every 5-7 days. The control group had large tumors 
with metastases and according to the institutional protocol, the group was exposed to euthanasia 
with inhalation of carbon dioxide after 26 days. Tumors were not observed in the lymph nodes and 
parenchymatous bodies in the experimental group mice. According to the evaluation criteria, 
tumorigenicity in the experimental group of tumor development was not found, whereas in the 
control group the development of tumors was 100%. The latent period of tumor formation in the 
control group was 10 days. 
Conclusion: In the course of the experiment, it was found that mesenchymal stem cells 
derived from human adipose tissue have not tumorigenic potential and can be considered in 
research for regenerative medicine. 
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